Re: you won’t see anyone buying this
in response to
by
posted on
Dec 11, 2023 01:16PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Hi Tada,
you said "KK2, fuzzyjr, Temsamany - the price of the ZHCLF shares on the market is not what Zenith Capital Corp is about"
A respectfully disagree , royalty based or not the share price is meaningful imo & should be a direct reflection of the possible strength of the royalty(s)?
If it's going to be some sort of incredible royalty stream based stock/play for decades being similar to a Pharma stock that pays dividends you would think investors would want in on this stock & early especially at these prices?
You can't receive royalties without holding the stock so the SP should reflect that at some point especially given all the possibilities.I don't see any volumes yet that would suggest this possible royalties strength.
One/ the royalties can't be strong with a pathetic SP , that doesn't make since , they both are either strong & healthy or there both weak & fragile. Thats what it's "about" its the whole package, both ends of it imo.
Am I wrong in this belief/thinking?